# Intra-arterial Methylprednisolone After Endovascular Thrombectomy

> **NCT07516522** · PHASE2 · RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 210 (estimated)

## Conditions studied

- Ischemia Stroke
- Thrombectomy
- Large Vessel Occlusion

## Interventions

- **DRUG:** The methylprednisolone sodium succinate group
- **DRUG:** The placebo group

## Key facts

- **NCT ID:** NCT07516522
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516522, "Intra-arterial Methylprednisolone After Endovascular Thrombectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07516522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*